Yang Heejung, Lee Dong Young, Kang Kyo Bin, Kim Jeom Yong, Kim Sun Ok, Yoo Young Hyo, Sung Sang Hyun
College of Pharmacy, Kangwon National University, Chuncheon 200-701, Republic of Korea.
College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University, Seoul 151-742, Republic of Korea.
J Pharm Biomed Anal. 2015 May 10;109:91-104. doi: 10.1016/j.jpba.2015.02.034. Epub 2015 Feb 25.
A dry purified extract of Panax ginseng (PEG) was prepared using a manufacturing process that includes column chromatography, acid hydrolysis, and an enzyme reaction. During the manufacturing process, the more polar ginsenosides were altered into less polar forms via cleavage of their sugar chains and structural modifications of the aglycones, such as hydroxylation and dehydroxylation. The structural changes of ginsenosides during the intermediate steps from dried ginseng extract (DGE) to PEG were monitored by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectroscopy (UPLC-QTOF/MS). 22 ginsenosides isolated from PEG were used as the reference standards for determining of unknown ginsenosides and further suggesting of the metabolic markers. The elution order of 22 ginsenosides based on the type of aglycones, and the location and number of sugar chains can be used for the structural elucidation of unknown ginsenosides. This information could be used in a dereplication process for quick and efficient identification of ginsenoside derivatives in ginseng preparations. A dereplication approach helped the identification of the metabolic markers in the UPLC-QTOF/MS chromatograms during the conversion process with multivariate analyses, including principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) plots. These metabolic markers were identified by comparing with the dereplication information of the reference standards of 22 ginsenosides, or they were assigned using the pattern of the MS/MS fragmented ions. Consequently, the developed metabolic profiling approach using UPLC-QTOF/MS and multivariate analysis represents a new method for providing quality control as well as useful criteria for a similarity evaluation of the manufacturing process of ginseng preparations.
采用包括柱色谱法、酸水解和酶反应的制造工艺制备了人参干燥纯化提取物(PEG)。在制造过程中,极性较强的人参皂苷通过糖链裂解和苷元结构修饰(如羟基化和脱羟基化)转变为极性较弱的形式。通过超高效液相色谱-四极杆飞行时间质谱联用(UPLC-QTOF/MS)监测从干燥人参提取物(DGE)到PEG的中间步骤中人参皂苷的结构变化。从PEG中分离出的22种人参皂苷用作测定未知人参皂苷和进一步推断代谢标志物的参考标准。基于苷元类型、糖链位置和数量的22种人参皂苷的洗脱顺序可用于未知人参皂苷的结构解析。该信息可用于在人参制剂中快速高效鉴定人参皂苷衍生物的去重复过程。去重复方法通过多变量分析(包括主成分分析(PCA)和正交偏最小二乘判别分析(OPLS-DA)图),在转化过程中帮助识别UPLC-QTOF/MS色谱图中的代谢标志物。通过与22种人参皂苷参考标准的去重复信息进行比较来鉴定这些代谢标志物,或者使用MS/MS碎片离子的模式进行指定。因此,所开发的使用UPLC-QTOF/MS和多变量分析的代谢谱分析方法代表了一种提供质量控制以及人参制剂制造过程相似性评估有用标准的新方法。